This article is focused on introducing a control chart technique using relative standard deviation (RSD) statistics (i.e., RSD chart); in other words, a coefficient of variation chart for continued process verification.
Relative standard deviation (RSD) limits were used in content uniformity in the past (before 2007). From a statistical point of view, RSD is one of the only few statistics that describes the term “uniformity” best. In a simulation study conducted by the author, both acceptance value (AV) and RSD distributions have a typical relationship where it was found that AV and RSD charts, when applied for continued process verification (CPV) purpose, can be constructed concurrently on the same chart frame to demonstrate their common overlay view. While RSD calculation is much more simple, RSD charts may also be applied to confirm the validity of AV charts in CPV exercise.
Click here for a PDF of this article.Submitted: May 23, 2022
Accepted: June 8, 2022
Pramote Cholayudth, cpramote2000@yahoo.com, is the founder and manager of PM Consult. He is an industrial pharmacist with more than 40 years of experience. He is a guest speaker on process validation to industrial pharmaceutical scientists organized by Thailand’s FDA.
Pharmaceutical Technology
Vol. 46, No. 7
July 2022
Pages: 44–47
When referring to this article, please cite it as P. Cholayudth, “Application of RSD Charts for Content Uniformity Data in Continued Process Verification,” Pharmaceutical Technology 46 (7) 44–47 (2022).
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
Legal and Regulatory Perspectives on 3D Printing: Drug Compounding Applications
December 10th 2024This paper explores the legal and regulatory framework around 3D drug printing, particularly for personalized medicine, considering regulatory compliance, business concerns, and intellectual property rights.